Inogen, Inc.
Inogen, Inc. (INGN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ingn · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Inogen, Inc. (INGN) measures how much investors pay for each dollar of the company's trailing earnings. INGN's current PE ratio of N/A is calculated by dividing its stock price of $6.19 by its TTM earnings per share of -$0.91.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2011 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 8 fiscal years · Front-end computedMinQ1 · 25%69.2x
MedianQ3 · 75%389.9x
Max
At N/A, INGN's current P/E is lower than in 0% of its annual fiscal year readings over the past 8 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Inogen, Inc.You INGN | $168M | N/A | — | -$0.91 |
 Perspective Therapeutics, Inc. CATX | $227M | N/A | — | -$1.40 |
 Eupraxia Pharmaceuticals Inc. EPRX | $202M | N/A | — | -$1.35 |
 Health Catalyst, Inc. HCAT | $135M | N/A | — | -$2.55 |
 Solana Company HSDT | $80M | N/A | — | -$1.85 |
 Nano-X Imaging Ltd. NNOX | $129M | N/A | — | -$1.16 |
 Outset Medical, Inc. OM | $81M | N/A | — | -$5.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.84 | — | |
2024-12-31 FY2024 | — | $-1.52 | — | |
2023-12-31 FY2023 | — | $-4.42 | — | |
2022-12-31 FY2022 | — | $-3.67 | — | |
2021-12-31 FY2021 | — | $-0.28 | — | |
2020-12-31 FY2020 | — | $-0.27 | — | |
2019-12-31 FY2019 | 71.17x | $0.96 | +32.0% | |
2018-12-31 FY2018 | 53.92x | $2.30 | -54.0% | |
2017-12-31 FY2017 | 117.28x | $1.02 | +78.5% | |
2016-12-31 FY2016 | 65.69x | $1.02 | -2.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Inogen, Inc. (INGN) measures how much investors pay for each dollar of the company's trailing earnings. INGN's current PE ratio of N/A is calculated by dividing its stock price of $6.19 by its TTM earnings per share of -$0.91.
Frequently asked questions
INGN pe ratio · 6 questionsINGN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $6.19 and TTM EPS of -$0.91. Data sourced from Financial Modeling Prep via INGN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Inogen, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08